Abstract:Abstract An acute respiratory disease, caused by a novel coronavirus (SARS-CoV-2, previously known as 2019-nCoV), the coronavirus disease 2019 (COVID-19) has spread throughout China and received worldwide attention. On 30 January 2020, World Health Organization (WHO) officially declared the COVID-19 epidemic as a public health emergency of international concern. The emergence of SARS-CoV-2, since the severe acute respiratory syndrome coronavirus (SARS-CoV) in 2002 and Middle East respiratory syndrome coronavirus (MERS-CoV) in 2012, marked the third introduction of a highly pathogenic and large-scale epidemic coronavirus into the human population in the twenty-first century. As of 1 March 2020, a total of 87,137 confirmed cases globally, 79,968 confirmed in China and 7169 outside of China, with 2977 deaths (3.4%) had been reported by WHO. Meanwhile, several independent research groups have identified that SARS-CoV-2 belongs to β-coronavirus, with highly identical genome to bat coronavirus, pointing to bat as the natural host. The novel coronavirus uses the same receptor, angiotensin-converting enzyme 2 (ACE2) as that for SARS-CoV, and mainly spreads through the respiratory tract. Importantly, increasingly evidence showed sustained human-to-human transmission, along with many exported cases across the globe. The clinical symptoms of COVID-19 patients include fever, cough, fatigue and a small population of patients appeared gastrointestinal infection symptoms. The elderly and people with underlying diseases are susceptible to infection and prone to serious outcomes, which may be associated with acute respiratory distress syndrome (ARDS) and cytokine storm. Currently, there are few specific antiviral strategies, but several potent candidates of antivirals and repurposed drugs are under urgent investigation. In this review, we summarized the latest research progress of the epidemiology, pathogenesis, and clinical characteristics of COVID-19, and discussed the current treatment and scientific advancements to combat the epidemic novel coronavirus.

The Global Battle Against SARS-CoV-2 and COVID-19

Current epidemiological and clinical features of COVID-19; a global perspective from China.

Progress in SARS-CoV-2, Diagnostic and Clinical Treatment of COVID-19

A 'special issue on COVID-19'. Fourteen primary care publications with implications for practice, teaching, and research

Summary of the clinical manifestations, infection mechanisms and current drug treatment of SARS-CoV-2 infection

[An analysis of global research on SARS-CoV-2].

Current Diagnostic and Therapeutic Strategies for COVID-19

A comprehensive overview on the transmission, pathogenesis, diagnosis, treatment, and prevention of SARS-CoV-2

SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic

Pathogen Evolution, Prevention/control Strategy and Clinical Features of COVID-19: Experiences from China

Virology, Epidemiology, Pathogenesis, and Control of COVID-19

Global scenario, public health concerns and mitigation strategies to counter current ongoing SARS-CoV-2 / COVID-19 pandemic

Recent Understandings Toward Coronavirus Disease 2019 (COVID-19): from Bench to Bedside

An Overview of SARS-COV-2: Virology, Epidemiology, Pathogenesis and Treatment

SARS-CoV-2: pathogenesis, therapeutics, variants, and vaccines

The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status

From SARS to COVID-19: What Lessons Have We Learned?

Advances in Pathogenesis, Progression, Potential Targets and Targeted Therapeutic Strategies in SARS-CoV-2-Induced COVID-19

Editorial of Special Column “research on Emerging COVID-19 (target, Mechanism, and Therapeutics)”

Global Emergence of SARS-CoV2 Infection and Scientific Interventions to Contain its Spread

COVID-19 Pandemic: Experiences in China and Implications for its Prevention and Treatment Worldwide